Argentina vs Belarus: Reported rate of new cervical cancer cases
Argentina
10.64 per 100,000 women
in 2017
Belarus
12.97 per 100,000 women
in 2017
Argentina rank
12th
Belarus rank
9th
Reported rate of new cervical cancer cases over time
- Argentina
- Belarus
How they compare
Belarus currently reports 12.97 per 100,000 women against 10.64 per 100,000 women in Argentina, a difference of 2.33 per 100,000 women.
That makes Belarus's figure about 1.2 times Argentina's.
The two have swapped places 3 times across 15 shared years of data; in 2003 it was Argentina ahead.
Argentina ranks 12th and Belarus ranks 9th of 46 countries.
Argentina has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Argentina | Belarus | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.9 per 100,000 women | 12.35 per 100,000 women | 1.55 per 100,000 women | Argentina |
| 2010s | 12.64 per 100,000 women | 12.51 per 100,000 women | 0.1227 per 100,000 women | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Argentina or Belarus?
- Belarus, at 12.97 per 100,000 women against 10.64 per 100,000 women in Argentina as of 2017.
- What is the difference in reported rate of new cervical cancer cases between Argentina and Belarus?
- 2.33 per 100,000 women, with Belarus ahead.
- How many years of comparable data are there for Argentina and Belarus?
- 15 years are reported by both, from 2003 to 2017.
- How do Argentina and Belarus rank globally for reported rate of new cervical cancer cases?
- Argentina ranks 12th and Belarus ranks 9th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) – processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.